Last Price
5.85
Today's Change
+2.00 (52.14%)
Day's Change
5.36 - 7.49
Trading Volume
56,540,369
Profile
KTTA
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Tiago Reis Marques M.D., Ph.D. Dr. Tiago Reis Marques M.D., Ph.D.
Full Time Employees: 8 8
IPO Date: 2021-09-15 2021-09-15
CIK: 0001841330 0001841330
ISIN: US70261F2020 US70261F2020
CUSIP: 70261F103 70261F103
Beta: 0.74 0.74
Last Dividend: 0.00 0.00
Dcf Diff: -6.67 -6.67
Dcf: 13.25 13.25
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Private Credit Faces Worst Reckoning Since 2008, NY Life CIO Says
2
CEO Morning Brief
3
CEO Morning Brief
US DOJ to Sue Visa Over Debit Card Market Monopoly, Bloomberg Reports
4
CEO Morning Brief
TikTok to Shut Down Its Music Streaming Business in November
5
CEO Morning Brief
Trump Dangles So Many Tax Breaks Even Some Advisers Are Confused
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
